D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
VTGN holding history
Vistagen Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VTGN overviewAll 13F holders of VTGNFull Q2 2026 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −13,274−100.0% | Sold out | Holders |
| Q2 2022 | 13,274 | $12.0K | <0.1% | −259,728−95.1% | Reduced | Holders |
| Q1 2022 | 273,002 | $339.0K | <0.1% | +259,601+1,937.2% | Added | Holders |
| Q4 2021 | 13,401 | $26.0K | <0.1% | −89,597−87.0% | Reduced | Holders |
| Q3 2021 | 102,998 | $282.0K | <0.1% | −41,756−28.8% | Reduced | Holders |
| Q2 2021 | 144,754 | $456.0K | <0.1% | +144,754 | New | Holders |